semaglutide and naion GLP-1 Medications NAION: What Patients Should Know About Sudden Vision Loss Semaglutide may be associated with

Tirzepatide was already approved to treat type 2 diabetes and was sold under the brand name Mounjaro

What the Retatrutide Phase 2 Trial Data Shows The Phase 2 human trial data on Retatrutide for obesity confirmed diarrhea was among the most commonly reported adverse events, occurring in a clear dose-dependent pattern

I started taking these to support my energy and overall well-being as I age, and I truly feel goodsteady, alert, and clear-minded

Scientific and institutional sources All figures and dates cited in this comparison are based on published clinical trials and the following official opinions, verified on May 8, 2026